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Background: Preeclampsia is a frequent syndrome and its cause has been linked to multiple factors, making
prevention of the syndrome a continuous challenge. One of the suggested risk factors for preeclampsia is advanced
maternal age. In the Western countries, maternal age at first delivery has been steadily increasing, yet few studies
have examined women of advanced maternal age with preeclampsia. The purpose of this registry-based study was
to compare the obstetric outcomes in primiparous and preeclamptic women younger and older than 35 years.
Methods: The registry-based study used data from three Finnish health registries: Finnish Medical Birth Register,
Finnish Hospital Discharge Register and Register of Congenital Malformations. The sample contained women under
35 years of age (N = 15,437) compared with those 35 and over (N = 2,387) who were diagnosed with preeclampsia
and had their first singleton birth in Finland between 1997 and 2008. In multivariate modeling, the main outcome
measures were Preterm delivery (before 34 and 37 weeks), low Apgar score (5 min.), small-for-gestational-age, fetal
death, asphyxia, Cesarean delivery, induction, blood transfusion and admission to a Neonatal Intensive Care Unit.
Results: Women of advanced maternal age (AMA) exhibited more preeclampsia (9.4%) than younger women
(6.4%). They had more prior terminations (<0.001), were more likely to have a body mass index (BMI) >25 (<0.001),
had more in vitro fertilization (IVF) (<0.001) and other fertility treatments (<0.001) and a higher incidence of
maternal diabetes (<0.001) and chronic hypertension (<0.001). Multivariate logistic regression indicated that women
of AMA had higher rates of: preterm delivery before 37 weeks 19.2% (OR 1.39 CI 1.24 to 1.56) and before 34 weeks
8.7% (OR 1.68 CI 1.43 to 2.00) low Apgar scores at 5 min. 7.1% (OR 1.37 CI 1.00 to 1.88), Small-for-Gestational Age
(SGA) 26.5% (OR 1.42 CI 1.28 to 1.57), Asphyxia 12.1% (OR 1.54 CI 1.34 to 1.77), Caesarean delivery 50% (OR 2.02 CI
1.84 to 2.20) and admission to a Neonatal Intensive Care Unit (NICU) 31.6% (OR 1.45 CI 1.32 to 1.60).
Conclusions: Preeclampsia is more common in women with advanced maternal age. Advanced maternal age is an
independent risk factor for adverse outcomes in first-time mothers with preeclampsia.Background
Maternal age at the time of first delivery has increased
in many Western countries [1]. A woman who is 35 years
or older at the time of delivery has been defined as being
of “advanced maternal age (AMA)” [2]. In Finland, the
mean age of women giving birth has, for a long time,
been around 30 years, and the average age in 2009 was
28 years among primigravidas. However, the proportion* Correspondence: reeta.lampinen@uef.fi
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distribution, and reproduction in any mediumof parturients aged over 35 in 2009 was 18.7%, and this
percentage has been consistently increasing [3].
Several studies have shown an association between
AMA and adverse perinatal outcomes as well as an
increased risk of certain pregnancy complications. Spe-
cifically, women of AMA have an increased risk of gesta-
tional diabetes, placenta previa [4-6], preeclampsia [5,7],
miscarriage [4], pregnancy-induced hypertension [5] and
the need for Caesarean deliveries [8]. Induction of labor
[5,9,10], augmentation with oxytocin and assisted deliv-
eries are also known to be associated with women of
AMA [10]. Furthermore, increasing maternal age contri-
butes to fetal, perinatal and neonatal death [5]. Womenntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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with chronic diseases, such as hypertensive disorders
and diabetes mellitus, thus further complicating their
pregnancies [4,5,7,9,10].
Preeclampsia is a frequent and potentially severe dis-
ease that affects about 3-8% of all pregnancies and
increases the mothers risk for morbidity [11-13]. Risks
associated with preeclampsia include nulliparity, pre-
existing medical conditions (e.g. hypertension, diabetes
mellitus and anti-phospholipid syndrome), plurality,
older maternal age and obesity [11,12]. The aim of this
study was to compare pregnancy outcomes in women
with preeclampsia aged 35 and over to those with pree-




The original dataset contained information on 690,555
women and their newborns, for births between the years
1997 and 2008. Eligibility criteria for this analysis
included primiparous women with singleton pregnancies
diagnosed with preeclampsia without malformations
(N= 17,824).
Approval for the study was obtained from the National
Institute for Health and Welfare (THL). The data used in
this study consisted of information from the Finnish Med-
ical Birth Register (MBR), Hospital Discharge Register
(HDR) and The Register of Congenital Malformations.
The THL stores information from each of these registers
and was responsible for providing all of the data.
The Finnish Medical Birth Register is a population-
based registry established in 1987 and is currently com-


















Figure 1 The data flow in the current study222223232323.maternal and neonatal birth characteristics and perinatal
outcomes for all women giving birth in Finland and all
newborns up to seven days of age. The form is filled in
by the hospital and sent, typically in electronic format,
to the THL [14].
The Hospital Discharge Register was established in
1967 and contains information on all aspects of inpatient
care in public and private hospitals and outpatient visits
to public hospitals (since 1996) in Finland. The data are
sent electronically to the THL by each setting [15].
The Register of Congenital Malformations is controlled
by THL and contains data on congenital chromosomal
and structural anomalies detected in stillborn and live
born infants and terminated fetuses from all healthcare
settings in Finland. The Register was established in 1962
and registration of anomaly data began in 1963 [16].
We compared women with preeclampsia who were of
AMA to women under the age of 35. The study group
contained 2,387 women aged 35 and over and the
control group included 15,437 women under the age of
35 (Figure 1).
Preeclampsia was defined as repeated periods of blood
pressure > 140/90 mmHg accompanied by proteinuria
(>0.3 g/day). Participants were identified in two ways.
First, we included eligible women based on diagnoses
recorded using ICD-10 codes (preeclampsia: ICD-10
codes O11, O14 and with seizures O15). All identified
cases of preeclamptic and eclamptic pregnancies were
used in the analysis. Second, we identified participants
who were hospitalized during pregnancy because of
hypertension. This was necessary because, in the MBR,
ICD-10 coding of diagnoses during pregnancy did not
start until 2004. Some of the women with preeclampsia
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lized because of hypertension; however, this diagnosis
generally identifies those with preeclampsia.
The following definitions were used to record preg-
nancy outcomes: preterm delivery, before 34 and 37 weeks
of gestation; Apgar score <7 at 5 minutes; and small for
gestational age (SGA), infants whose sex- and age-
adjusted birth weight was below the tenth percentile
according to the normal tables for our population [17].
Statistical analysis
Statistical analysis was conducted using SPSS for Win-
dows, version 17. Statistical differences between the
study and control groups were evaluated using chi
square-tests for dichotomous variables; continuous vari-
ables were analyzed using independent sample t-tests.
All variables used in the binary logistic regression ana-
lysis were dichotomous and missing data for any variable
were categorized as “no” (=0). Binary logistic regression
adjusted for potential confounding factors included prior
termination, placenta previa, IVF, fertility treatment
other than IVF, smoking, maternal age (in the categories
under 35 and 35 and over), maternal diabetes (including
both pre-pregnancy and gestational diabetes) and BMI
>25 before pregnancy. Because maternal height and
weight have been recorded in the data sources only since
2004, logistic regression is presented primarily without
BMI (Table 1). To compare the pregnancy outcomes of
women with preeclampsia under 35 years of age to those
aged 35 and over, odds ratios with 95% confidence inter-
vals were estimated.
Results
Preeclampsia was identified in 9.4% of women of AMA and
6.4% of women under 35 years of age. The mean (± standard
deviation) ages of the control (<35) and study groups (>35)
were 26.6±4.2 years and 37.5±2.3 years, respectively. TheTable 1 Results of binary logistic regression analysis of wome
(* BMI included)
Outcome <35 ≥35
Preterm delivery (before <34 wk) 830 (5.5) 203 (8.7)
Preterm delivery (before 37 wk) 2231 (14.5) 457 (19.2)
Low Apgar score (<7) at 5 min 276 (5.5) 52 (7.1)
SGA (<90th percentile) 3233 (21.0) 632 (26.5)
Fetal death 28 (0.2) 6 (0.3)
Asphyxia 1229 (8.0) 289 (12.1)
Cesarean 4928 (31.9) 1192 (50.0)
Induction 12115 (78.5) 1697 (71.1)
Eclampsia 157 (1.0) 20 (0.8)
Blood transfusion 244 (1.6) 38 (1.6)
Admission to a neonatal unit 3650 (23.6) 755 (31.6)groups were different in terms of prior terminations,
pre-pregnancy obesity (BMI >25), IVF and other fertility
treatments, smoking, chronic hypertension and maternal
diabetes. Table 2 summarizes the background information
for the two groups.
The mean weight before pregnancy in the control
group was 69.6 ± 16.3 kg versus 73.9 ± 16.3 kg (<0.001)
in the study group. In the control group the mean birth
weight was 3179 ± 730.4 g versus 3037 ± 788.3 g (<0.001)
in the study group. Pregnancy outcomes for the two
groups are compared in Table 1.
Cesarean delivery was found to be twice as likely in
women of AMA. The rate of preterm delivery before 34
and 37 weeks’ gestation, low Apgar score at 5 min.,
SGA, asphyxia and admission to a NICU were also sig-
nificantly higher in women of AMA. No significant dif-
ferences between groups were found in rates of fetal
death, eclampsia and blood transfusion to mothers.
Discussion
Women of AMA were 1.5 times more likely to have pre-
eclampsia compared to women under 35 years of age.
The main finding of the present study, however, was that
among preeclamptic women, adverse pregnancy out-
comes were more common in women of AMA.
First, women of AMA were significantly more likely to
have preterm deliveries before 34 and 37 weeks and to
have SGA- infants the risk increase being 70% in pre-
term delivery before 34 weeks and 40% in both preterm
delivery before 37 weeks and SGA. Second, women of
AMA had a twofold increased risk of requiring Cesarean
deliveries. Finally, these obstetric risks led to approxi-
mately 50% higher frequencies of neonatal asphyxia and
40% of admission of the infant in the neonatal intensive
care unit.
Similar to other studies, the women of AMA in this
sample experienced more prior terminations and IVFn aged under 35 and 35 and over with preeclampsia
Adjusted P Adjusted OR 95% CI
<0.000 (* < 0.000) 1.68 (*1.81) 1.43-2.00 (*1.36-2.42)
<0.001 (*0,002) 1.39 (*1.36) 1.24-1.56 (*1.12-1.65)
0.048 (*0.122) 1.37 (*1.30) 1.00-1.89 (*0.93-1.83)
<0.001 (* < 0.001) 1.42 (*1.53) 1.28-1.57 (*1.29-1.82)
0.781 (*0.964) 1.14 (*0.96) 0.45-2.86 (*0.19-4.98)
<0.001 (*0.006) 1.54 (*1.38) 1.34-1.77 (*1.10-1.73)
<0.001 (* < 0.001) 2.02 (*1.86) 1.84-2.20 (*1.60-2.17)
<0.001 (*0.001) 0.67 (*0.73) 0.61-0.74 (*0.61-0.87)
0.279 (*0.752) 0.77 (*1.13) 0.48-1.23 (*0.54-2.34)
0.311 (*0.437) 0.83 (*0.85) 0.58-1.19 (*0.57-1.27)
<0.001 (* < 0.001) 1.45 (*1.42) 1.32-1.60 (*1.20-1.65)
Table 2 Background information about women aged
under 35 and 35 and over who had preeclampsia
Women <35 Women ≥35
(n = 15 437) (n = 2387) P
Prior termination 3237 (21.0) 812 (34.0) <0.001
Pregravid BMI >25 kg/m2 2201 (41.6) 470 (56.2) <0.001
Late pregnancy bleeding 215 (1.4) 45 (1.9) 0.062
Placenta previa 29 (0.2) 11 (0.5) 0.009
Fertility treatment other than IVF 274 (1.8) 154 (6.5) <0.001
IVF 291 (1.9) 184 (7.7) <0.001
Anemia 91 (0.6) 14 (0.6) 0.986
Smoking 2196 (14.2) 226 (9.5) <0.001
Not married 7346 (47.6) 1128 (47.3) 0.058
Chronic hypertension 177 (1.1) 49 (2.1) <0.001
Maternal diabetes 753 (4.9) 221 (9.3) <0.001
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hand, they smoked less often than younger women, but
they were more often obese and had higher rates of ges-
tational diabetes. Obesity is known to be a risk factor for
preeclampsia [12], whereas smoking is a protective fac-
tor [21]. The net effect of maternal obstetric history and
health behavior is likely to play a minor or moderate role
in the entire picture, since some of the effects are benefi-
cial while others are harmful depending on whether the
outcome under consideration is the frequency of pree-
clampsia, premature delivery, fetal growth or neonatal
outcome [8,18,22-25]. In other words, maternal age
appeared to be an independent obstetric risk factor for
early onset of preeclampsia and impaired fetal growth. It
has also been stated that chronic and pregnancy-related
hypertension increase risk for low birthweight and pre-
term birth as well as older maternal age was resulting in
shorter gestations [26].
The mechanism behind this risk is beyond the scope
of the present study but may be related to aging of the
uterine blood vessels [27].
The strength of the current study was that it used a
population-based cohort including data from three na-
tional Finnish health registries. The data stored in these
registries have demonstrated both high quality and valid-
ity [28], affirming that the registries are a valuable re-
source for studying maternal and obstetric health
outcomes as the identification of preeclampsia is shown
to be accurate in such databases [29]. Weaknesses of the
study were that there may have been some error in the
data collection, such as coding errors; however, consider-
ing the size of the data set, the impact of this factor was
probably minor. It is also possible that picking out pree-
clamptic and eclamptic women from the data on the
basis of diagnoses and hospital stay may have slightly
increased the number in the sample. However, the datawas recorded using a standard format among the regis-
tries and therefore, any inconsistency in reporting would
have been a random event independent of maternal age.
Conclusions
In this study, women of AMA had preeclampsia more
often than younger women, and their pregnancies were
more likely to be complicated by preterm deliveries and
impaired fetal growth. As a consequence, the need for
neonatal intensive care was significantly higher for
women of AMA, suggesting a substantial increase in the
use of healthcare resources. Premature infants are at
higher risk of neonatal mortality and morbidity as well
as neurodevelopmental impairments; these tend to be
inversely proportional to gestational age [30]. The pre-
ventive measures, such as taking supplements of vita-
mins C and E, do not reduce the occurrence of
preeclampsia [31] but it has been demonstrated that
low-dose aspirin started in early pregnancy may reduce
the incidence of preeclampsia and intrauterine growth
restriction [32]. However, postponing pregnancy to an
older age is an obvious risk and the implications for the
timing of assisted reproduction and family planning
policies are relevant.
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